Literature DB >> 20227367

MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Jakub Godlewski1, Michal O Nowicki, Agnieszka Bronisz, Gerard Nuovo, Jeff Palatini, Michael De Lay, James Van Brocklyn, Michael C Ostrowski, E Antonio Chiocca, Sean E Lawler.   

Abstract

To sustain tumor growth, cancer cells must be able to adapt to fluctuations in energy availability. We have identified a single microRNA that controls glioma cell proliferation, migration, and responsiveness to glucose deprivation. Abundant glucose allows relatively high miR-451 expression, promoting cell growth. In low glucose, miR-451 levels decrease, slowing proliferation but enhancing migration and survival. This allows cells to survive metabolic stress and seek out favorable growth conditions. In glioblastoma patients, elevated miR-451 is associated with shorter survival. The effects of miR-451 are mediated by LKB1, which it represses through targeting its binding partner, CAB39 (MO25 alpha). Overexpression of miR-451 sensitized cells to glucose deprivation, suggesting that its downregulation is necessary for robust activation of LKB1 in response to metabolic stress. Thus, miR-451 is a regulator of the LKB1/AMPK pathway, and this may represent a fundamental mechanism that contributes to cellular adaptation in response to altered energy availability. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227367      PMCID: PMC3125113          DOI: 10.1016/j.molcel.2010.02.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  53 in total

Review 1.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

2.  LKB1 regulates neuronal migration and neuronal differentiation in the developing neocortex through centrosomal positioning.

Authors:  Naoyuki Asada; Kamon Sanada; Yoshitaka Fukada
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

Review 3.  mTOR and cancer therapy.

Authors:  J B Easton; P J Houghton
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

Review 4.  Cancer's molecular sweet tooth and the Warburg effect.

Authors:  Jung-whan Kim; Chi V Dang
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 5.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

Authors:  D Grahame Hardie
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

6.  The LKB1 tumor suppressor negatively regulates mTOR signaling.

Authors:  Reuben J Shaw; Nabeel Bardeesy; Brendan D Manning; Lyle Lopez; Monica Kosmatka; Ronald A DePinho; Lewis C Cantley
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

7.  Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.

Authors:  Edward J Miller; Ji Li; Lin Leng; Courtney McDonald; Toshiya Atsumi; Richard Bucala; Lawrence H Young
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family.

Authors:  Matthew J Sanders; Zahabia S Ali; Bronwyn D Hegarty; Richard Heath; Michael A Snowden; David Carling
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

View more
  201 in total

1.  Probucol suppresses human glioma cell proliferation in vitro via ROS production and LKB1-AMPK activation.

Authors:  Yong-sheng Jiang; Jing-an Lei; Fang Feng; Qi-ming Liang; Fu-rong Wang
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

2.  Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.

Authors:  Chan Gyu Lee; Young Woo Kim; Eun Hyun Kim; Zhipeng Meng; Wendong Huang; Se Jin Hwang; Sang Geon Kim
Journal:  Gastroenterology       Date:  2012-01-18       Impact factor: 22.682

Review 3.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

4.  miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.

Authors:  Duonan Yu; Camila O dos Santos; Guowei Zhao; Jing Jiang; Julio D Amigo; Eugene Khandros; Louis C Dore; Yu Yao; Janine D'Souza; Zhe Zhang; Saghi Ghaffari; John Choi; Sherree Friend; Wei Tong; Jordan S Orange; Barry H Paw; Mitchell J Weiss
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

5.  MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.

Authors:  Pin Yin; Rui Peng; Huimin Peng; Li Yao; Yan Sun; Li Wen; Tianhui Wu; Ji Zhou; Zheng Zhang
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

6.  Optimal control strategies of eradicating invisible glioblastoma cells after conventional surgery.

Authors:  Aurelio A de Los Reyes V; Eunok Jung; Yangjin Kim
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

7.  Glucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.

Authors:  Khairul I Ansari; Daisuke Ogawa; Arun K Rooj; Sean E Lawler; Anna M Krichevsky; Mark D Johnson; E Antonio Chiocca; Agnieszka Bronisz; Jakub Godlewski
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 8.  Life history trade-offs in cancer evolution.

Authors:  C Athena Aktipis; Amy M Boddy; Robert A Gatenby; Joel S Brown; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2013-11-11       Impact factor: 60.716

Review 9.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

10.  microRNA Regulation and Its Consequences in Cancer.

Authors:  Sonya Parpart; Xin Wei Wang
Journal:  Curr Pathobiol Rep       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.